- Home
- ALVO vs IRMD Comparison
ALVO vs IRMD Comparison
Compare ALVO & IRMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ALVO | IRMD |
|---|---|---|
| Founded | 2013 | 1992 |
| Country | Luxembourg | United States |
| Employees | 1460 | 166 |
| Industry | Biotechnology: Pharmaceutical Preparations | Medical/Dental Instruments |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.1B | 1.2B |
| IPO Year | N/A | 2014 |
Fundamental Metrics
Financial Performance| Metric | ALVO | IRMD |
|---|---|---|
| Price | $4.17 | $93.60 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 4 | 1 |
| Target Price | $8.00 | ★ $116.00 |
| AVG Volume (30 Days) | ★ 721.1K | 125.3K |
| Earning Date | 05-06-2026 | 05-01-2026 |
| Dividend Yield | N/A | ★ 0.95% |
| EPS Growth | N/A | ★ 16.67 |
| EPS | N/A | ★ 0.45 |
| Revenue | N/A | ★ $83,814,000.00 |
| Revenue This Year | $13.28 | $12.38 |
| Revenue Next Year | $18.63 | $11.31 |
| P/E Ratio | ★ $18.20 | $213.91 |
| Revenue Growth | N/A | ★ 14.43 |
| 52 Week Low | $2.94 | $55.11 |
| 52 Week High | $9.94 | $107.90 |
Technical Indicators
Market Signals| Indicator | ALVO | IRMD |
|---|---|---|
| Relative Strength Index (RSI) | 64.02 | 53.63 |
| Support Level | $3.09 | $90.03 |
| Resistance Level | $5.46 | $97.36 |
| Average True Range (ATR) | 0.28 | 3.18 |
| MACD | 0.11 | 0.43 |
| Stochastic Oscillator | 76.06 | 51.24 |
Price Performance
Historical ComparisonAbout ALVO Alvotech
Alvotech is a biopharmaceutical company focused solely on the development and manufacture of biosimilar medicines for patients globally. Its purpose is to improve the health and quality of life of patients around the world by improving access to treatments for various diseases. The company's commercialized products incldue AVT02, AVT03, AVT04, AVT05, and AVT06. Its pipeline contains eight biosimilar candidates aimed at treating autoimmune disorders, eye disorders, osteoporosis, and cancer. Geographically, the company generates the majority of revenue from Europe, and the rest from the USA and the rest of the world.
About IRMD iRadimed Corporation
iRadimed Corp develops, manufactures, markets, and distributes a Magnetic Resonance Imaging (MRI) compatible intravenous (IV) infusion pump system, and MRI compatible patient vital signs monitoring system, and accessories and services relating to them. The company provides a non-magnetic IV infusion pump system, which is designed to be safe for use during MRI procedures. The MRI products of the company are sold to hospitals and acute care facilities in the United States and internationally. It generates the majority revenue from United States.